CN108498398A - 一种紫草健康舒敏精华液及其制备方法 - Google Patents
一种紫草健康舒敏精华液及其制备方法 Download PDFInfo
- Publication number
- CN108498398A CN108498398A CN201810391997.6A CN201810391997A CN108498398A CN 108498398 A CN108498398 A CN 108498398A CN 201810391997 A CN201810391997 A CN 201810391997A CN 108498398 A CN108498398 A CN 108498398A
- Authority
- CN
- China
- Prior art keywords
- mixed solution
- asian puccoon
- essence
- minutes
- natural activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
本发明公开一种紫草健康舒敏精华液及其制备方法,包括水、二钠、尿囊素、丙二醇、透明质酸钠、增稠凝胶剂、氨甲基丙醇、D‑泛醇、四氢甲基嘧啶羧酸、甘草酸二钾、天然活性复合多糖保湿因子、天然活性紫草多酚、1,3‑丁二醇、辛酰羟肟酸、液体防腐剂、增溶剂、洋甘菊香精和聚甘油。本发明具备保湿、营养、舒敏、易吸收、略微成膜及透气好等优点,能够增强皮肤抗过敏能力,抵御外界有害物质的损害,抗衰老、祛痘印、改善皮肤毛细血管微循环,使皮肤表面形成光滑吸湿膜,增加皮肤的含水量。
Description
技术领域
本发明涉及化妆品技术领域,具体是一种紫草健康舒敏精华液及其制备方法。
背景技术
精华液,是护肤品中之极品,成分精致、功效强大、效果显著,始终保持着它拥有的高贵和神秘。精华液含有微量元素、胶原蛋白、血清,它的作用有防衰老、抗皱、保湿、美白、去斑等等。女人过了25岁的往往会因为年龄的增长或疲劳压力而肤色灰暗、干燥,应该从此时就开始重视美白保湿。精华液是一种很好的护肤品,它不像遮瑕膏、粉底、散粉、粉饼这些只能暂时掩盖皮肤灰暗,而且把内在肤质调理好,根治影响美白的罪魁祸首黑色素,肌肤才能展现真正由内而外的自然美白光彩。
发明内容
本发明的目的在于针对现有技术的缺陷和不足,提供一种紫草健康舒敏精华液及其制备方法。
为实现上述目的,本发明采用的技术方案是:一种紫草健康舒敏精华液,其创新点在于:包括水、二钠、尿囊素、丙二醇、透明质酸钠、增稠凝胶剂、氨甲基丙醇、D-泛醇、四氢甲基嘧啶羧酸、甘草酸二钾、天然活性复合多糖保湿因子、天然活性紫草多酚、1,3-丁二醇、辛酰羟肟酸、液体防腐剂、增溶剂、洋甘菊香精和聚甘油。
进一步的,按照精华液的总质量百分比计,各组分的含量为:水65%-78.3%、二钠0.01%-0.08%、尿囊素0.05%-0.95%、丙二醇1.0%-5.0%、透明质酸钠0.11%-0.33%、增稠凝胶剂0.5%-0.8%、氨甲基丙醇0.14%、D-泛醇1.0%、四氢甲基嘧啶羧酸0.02%-0.25%、甘草酸二钾0.02%-0.25%、天然活性复合多糖保湿因子2.5%-6.6%、天然活性紫草多酚1.8%-3.5%、1,3-丁二醇4.0%-6.1%、辛酰羟肟酸1.0%-2.3%、液体防腐剂0.2%、增溶剂0.04%、洋甘菊香精0.01%和聚甘油0.2%。
还包括一种紫草健康舒敏精华液的制备方法,其特征在于,包括以下步骤:
S1、彻底清洗并消毒相关生产设备和相关生产用具,并逐一备好料;
S2、将水烧开至100℃,并加入二钠和尿囊素进行充分混合,形成混合溶液A;
S3、将丙二醇、透明质酸钠、增稠凝胶剂进行混合搅拌分散后形成混合溶液B,然后将混合溶液B与混合溶液A进行搅拌得到混合溶液C,然后均质10分钟,速度为50r/min,再加热至90-95℃,搅拌速度为25r/min,再均质5分钟,速度为50r/min,并保温30分钟以上;
S4、将混合溶液C降温至70℃,然后加入氨甲基丙醇,并搅拌5分钟,搅拌速度为25r/min,得到混合溶液D;
S5、将混合溶液D降温至50-55℃,并依次加入D-泛醇、四氢甲基嘧啶羧酸、甘草酸二钾、天然活性复合多糖保湿因子和天然活性紫草多酚,进行搅拌均匀,搅拌速度为25r/min,得到混合溶液E;
S6、将1,3-丁二醇、辛酰羟肟酸和液体防腐剂混合搅拌至透明后加入至混合溶液F中,且搅拌均匀并透明,得到混合溶液G;
S7、将增溶剂和洋甘菊香精搅拌透明后加入至混合溶液G中,搅拌至完全透明和均匀,得到混合溶液H;
S8、将聚甘油和同等质量百分比的水进行混合搅拌均匀后,加入至混合溶液H中,搅拌15分钟以上,搅拌速度为25r/min,直至完全均匀,得到半成品精华液;
S9、将半成品精华液检测合格后,降温到40℃以下过滤后得到本产品精华液。
采用上述结构后,本发明有益效果为:
本发明具备保湿、营养、舒敏、易吸收、略微成膜及透气好等优点,能够增强皮肤抗过敏能力,抵御外界有害物质的损害,抗衰老、祛痘印、改善皮肤毛细血管微循环,使皮肤表面形成光滑吸湿膜,增加皮肤的含水量。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下以具体实施方式,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施方式仅用以解释本发明,并不用于限定本发明。
实施例1
一种紫草健康舒敏精华液,按照精华液的总质量百分比计,各组分的含量为:水65%、二钠0.01%、尿囊素0.05%、丙二醇1.0%、透明质酸钠0.11%、增稠凝胶剂0.5%、氨甲基丙醇0.14%、D-泛醇1.0%、四氢甲基嘧啶羧酸0.02%、甘草酸二钾0.02%、天然活性复合多糖保湿因子2.5%、天然活性紫草多酚1.8%、1,3-丁二醇4.0%、辛酰羟肟酸1.0%、液体防腐剂0.2%、增溶剂0.04%、洋甘菊香精0.01%和聚甘油0.2%。
还包括一种紫草健康舒敏精华液的制备方法,包括以下步骤:
S1、彻底清洗并消毒相关生产设备和相关生产用具,并逐一备好料;
S2、将水烧开至100℃,并加入二钠和尿囊素进行充分混合,形成混合溶液A;
S3、将丙二醇、透明质酸钠、增稠凝胶剂进行混合搅拌分散后形成混合溶液B,然后将混合溶液B与混合溶液A进行搅拌得到混合溶液C,然后均质10分钟,速度为50r/min,再加热至90-95℃,搅拌速度为25r/min,再均质5分钟,速度为50r/min,并保温30分钟以上;
S4、将混合溶液C降温至70℃,然后加入氨甲基丙醇,并搅拌5分钟,搅拌速度为25r/min,得到混合溶液D;
S5、将混合溶液D降温至50-55℃,并依次加入D-泛醇、四氢甲基嘧啶羧酸、甘草酸二钾、天然活性复合多糖保湿因子和天然活性紫草多酚,进行搅拌均匀,搅拌速度为25r/min,得到混合溶液E;
S6、将1,3-丁二醇、辛酰羟肟酸和液体防腐剂混合搅拌至透明后加入至混合溶液F中,且搅拌均匀并透明,得到混合溶液G;
S7、将增溶剂和洋甘菊香精搅拌透明后加入至混合溶液G中,搅拌至完全透明和均匀,得到混合溶液H;
S8、将聚甘油和同等质量百分比的水进行混合搅拌均匀后,加入至混合溶液H中,搅拌15分钟以上,搅拌速度为25r/min,直至完全均匀,得到半成品精华液;
S9、将半成品精华液检测合格后,降温到40℃以下过滤后得到本产品精华液。
实施例2
一种紫草健康舒敏精华液,按照精华液的总质量百分比计,各组分的含量为:水78.3%、0.08%、尿囊素0.95%、丙二醇5.0%、透明质酸钠0.33%、增稠凝胶剂0.8%、氨甲基丙醇0.14%、D-泛醇1.0%、四氢甲基嘧啶羧酸0.25%、甘草酸二钾0.25%、天然活性复合多糖保湿因子6.6%、天然活性紫草多酚3.5%、1,3-丁二醇6.1%、辛酰羟肟酸2.3%、液体防腐剂0.2%、增溶剂0.04%、洋甘菊香精0.01%和聚甘油0.2%。
还包括一种紫草健康舒敏精华液的制备方法,包括以下步骤:
S1、彻底清洗并消毒相关生产设备和相关生产用具,并逐一备好料;
S2、将水烧开至100℃,并加入二钠和尿囊素进行充分混合,形成混合溶液A;
S3、将丙二醇、透明质酸钠、增稠凝胶剂进行混合搅拌分散后形成混合溶液B,然后将混合溶液B与混合溶液A进行搅拌得到混合溶液C,然后均质10分钟,速度为50r/min,再加热至90-95℃,搅拌速度为25r/min,再均质5分钟,速度为50r/min,并保温30分钟以上;
S4、将混合溶液C降温至70℃,然后加入氨甲基丙醇,并搅拌5分钟,搅拌速度为25r/min,得到混合溶液D;
S5、将混合溶液D降温至50-55℃,并依次加入D-泛醇、四氢甲基嘧啶羧酸、甘草酸二钾、天然活性复合多糖保湿因子和天然活性紫草多酚,进行搅拌均匀,搅拌速度为25r/min,得到混合溶液E;
S6、将1,3-丁二醇、辛酰羟肟酸和液体防腐剂混合搅拌至透明后加入至混合溶液F中,且搅拌均匀并透明,得到混合溶液G;
S7、将增溶剂和洋甘菊香精搅拌透明后加入至混合溶液G中,搅拌至完全透明和均匀,得到混合溶液H;
S8、将聚甘油和同等质量百分比的水进行混合搅拌均匀后,加入至混合溶液H中,搅拌15分钟以上,搅拌速度为25r/min,直至完全均匀,得到半成品精华液;
S9、将半成品精华液检测合格后,降温到40℃以下过滤后得到本产品精华液。
实施例3
一种紫草健康舒敏精华液,按照精华液的总质量百分比计,各组分的含量为:水70%、二钠0.05%、尿囊素0.07%、丙二醇3.0%、透明质酸钠0.22%、增稠凝胶剂0.7%、氨甲基丙醇0.14%、D-泛醇1.0%、四氢甲基嘧啶羧酸0.15%、甘草酸二钾0.2%、天然活性复合多糖保湿因子4.5%、天然活性紫草多酚2.2%、1,3-丁二醇5.0%、辛酰羟肟酸1.8%、液体防腐剂0.2%、增溶剂0.04%、洋甘菊香精0.01%和聚甘油0.2%。
还包括一种紫草健康舒敏精华液的制备方法,包括以下步骤:
S1、彻底清洗并消毒相关生产设备和相关生产用具,并逐一备好料;
S2、将水烧开至100℃,并加入二钠和尿囊素进行充分混合,形成混合溶液A;
S3、将丙二醇、透明质酸钠、增稠凝胶剂进行混合搅拌分散后形成混合溶液B,然后将混合溶液B与混合溶液A进行搅拌得到混合溶液C,然后均质10分钟,速度为50r/min,再加热至90-95℃,搅拌速度为25r/min,再均质5分钟,速度为50r/min,并保温30分钟以上;
S4、将混合溶液C降温至70℃,然后加入氨甲基丙醇,并搅拌5分钟,搅拌速度为25r/min,得到混合溶液D;
S5、将混合溶液D降温至50-55℃,并依次加入D-泛醇、四氢甲基嘧啶羧酸、甘草酸二钾、天然活性复合多糖保湿因子和天然活性紫草多酚,进行搅拌均匀,搅拌速度为25r/min,得到混合溶液E;
S6、将1,3-丁二醇、辛酰羟肟酸和液体防腐剂混合搅拌至透明后加入至混合溶液F中,且搅拌均匀并透明,得到混合溶液G;
S7、将增溶剂和洋甘菊香精搅拌透明后加入至混合溶液G中,搅拌至完全透明和均匀,得到混合溶液H;
S8、将聚甘油和同等质量百分比的水进行混合搅拌均匀后,加入至混合溶液H中,搅拌15分钟以上,搅拌速度为25r/min,直至完全均匀,得到半成品精华液;
S9、将半成品精华液检测合格后,降温到40℃以下过滤后得到本产品精华液。
以上所述,仅用以说明本发明的技术方案而非限制,本领域普通技术人员对本发明的技术方案所做的其它修改或者等同替换,只要不脱离本发明技术方案的精神和范围,均应涵盖在本发明的权利要求范围当中。
Claims (3)
1.一种紫草健康舒敏精华液,其特征在于:包括水、二钠、尿囊素、丙二醇、透明质酸钠、增稠凝胶剂、氨甲基丙醇、D-泛醇、四氢甲基嘧啶羧酸、甘草酸二钾、天然活性复合多糖保湿因子、天然活性紫草多酚、1,3-丁二醇、辛酰羟肟酸、液体防腐剂、增溶剂、洋甘菊香精和聚甘油。
2.根据权利要求1所述的一种紫草健康舒敏精华液,其特征在于:按照精华液的总质量百分比计,各组分的含量为:水65%-78.3%、二钠0.01%-0.08%、尿囊素0.05%-0.95%、丙二醇1.0%-5.0%、透明质酸钠0.11%-0.33%、增稠凝胶剂0.5%-0.8%、氨甲基丙醇0.14%、D-泛醇1.0%、四氢甲基嘧啶羧酸0.02%-0.25%、甘草酸二钾0.02%-0.25%、天然活性复合多糖保湿因子2.5%-6.6%、天然活性紫草多酚1.8%-3.5%、1,3-丁二醇4.0%-6.1%、辛酰羟肟酸1.0%-2.3%、液体防腐剂0.2%、增溶剂0.04%、洋甘菊香精0.01%和聚甘油0.2%。
3.一种根据权利要求1所述的一种紫草健康舒敏精华液的制备方法,其特征在于,包括以下步骤:
S1、彻底清洗并消毒相关生产设备和相关生产用具,并逐一备好料;
S2、将水烧开至100℃,并加入二钠和尿囊素进行充分混合,形成混合溶液A;
S3、将丙二醇、透明质酸钠、增稠凝胶剂进行混合搅拌分散后形成混合溶液B,然后将混合溶液B与混合溶液A进行搅拌得到混合溶液C,然后均质10分钟,速度为50r/min,再加热至90-95℃,搅拌速度为25r/min,再均质5分钟,速度为50r/min,并保温30分钟以上;
S4、将混合溶液C降温至70℃,然后加入氨甲基丙醇,并搅拌5分钟,搅拌速度为25r/min,得到混合溶液D;
S5、将混合溶液D降温至50-55℃,并依次加入D-泛醇、四氢甲基嘧啶羧酸、甘草酸二钾、天然活性复合多糖保湿因子和天然活性紫草多酚,进行搅拌均匀,搅拌速度为25r/min,得到混合溶液E;
S6、将1,3-丁二醇、辛酰羟肟酸和液体防腐剂混合搅拌至透明后加入至混合溶液F中,且搅拌均匀并透明,得到混合溶液G;
S7、将增溶剂和洋甘菊香精搅拌透明后加入至混合溶液G中,搅拌至完全透明和均匀,得到混合溶液H;
S8、将聚甘油和同等质量百分比的水进行混合搅拌均匀后,加入至混合溶液H中,搅拌15分钟以上,搅拌速度为25r/min,直至完全均匀,得到半成品精华液;
S9、将半成品精华液检测合格后,降温到40℃以下过滤后得到本产品精华液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810391997.6A CN108498398A (zh) | 2018-04-27 | 2018-04-27 | 一种紫草健康舒敏精华液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810391997.6A CN108498398A (zh) | 2018-04-27 | 2018-04-27 | 一种紫草健康舒敏精华液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108498398A true CN108498398A (zh) | 2018-09-07 |
Family
ID=63399108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810391997.6A Pending CN108498398A (zh) | 2018-04-27 | 2018-04-27 | 一种紫草健康舒敏精华液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108498398A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110623888A (zh) * | 2019-11-04 | 2019-12-31 | 菲朗生物科技(湖北)有限公司 | 一种草本舒缓精华液及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007077089A (ja) * | 2005-09-15 | 2007-03-29 | Noevir Co Ltd | 美肌用組成物 |
CN103876988A (zh) * | 2014-04-04 | 2014-06-25 | 广州丹奇日用化工厂有限公司 | 一种紫草茎叶中提取黄酮的方法及其在化妆品中的应用 |
CN105662955A (zh) * | 2016-01-27 | 2016-06-15 | 安婕妤化妆品科技股份有限公司 | 一种含有甲基嘧啶类物质的化妆品 |
-
2018
- 2018-04-27 CN CN201810391997.6A patent/CN108498398A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007077089A (ja) * | 2005-09-15 | 2007-03-29 | Noevir Co Ltd | 美肌用組成物 |
CN103876988A (zh) * | 2014-04-04 | 2014-06-25 | 广州丹奇日用化工厂有限公司 | 一种紫草茎叶中提取黄酮的方法及其在化妆品中的应用 |
CN105662955A (zh) * | 2016-01-27 | 2016-06-15 | 安婕妤化妆品科技股份有限公司 | 一种含有甲基嘧啶类物质的化妆品 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110623888A (zh) * | 2019-11-04 | 2019-12-31 | 菲朗生物科技(湖北)有限公司 | 一种草本舒缓精华液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI753901B (zh) | 發芽糙米之佛羅拿酵母菌發酵液 | |
CN106074256A (zh) | 一种固体喷雾卸妆凝胶及其制备方法与应用 | |
CN103202788A (zh) | 一种以柿叶提取物为功能原料的淡斑霜 | |
CN105769730B (zh) | 一种沉香珍珠氨基酸皂及其制备方法 | |
CN103690391A (zh) | 一种神经酰胺纳米乳液及其制备方法 | |
EP3552598A1 (en) | Composition containing crocus sativus extract and preparation method and use thereof | |
CN104887612A (zh) | 一种含3d极化水的补水液 | |
CN105686978B (zh) | 一种持久保湿的皮肤清洁组合物 | |
CN108498398A (zh) | 一种紫草健康舒敏精华液及其制备方法 | |
CN108066245A (zh) | 一种美白保湿原液及其制备方法 | |
CN107669541A (zh) | 一种净润去屑洗发露 | |
CN109846810A (zh) | 一种美容面膜及其制备方法 | |
CN105395450A (zh) | 一种豆腐柴乳酸敷面剂 | |
CN109908030A (zh) | 一种无水面膜的制作工艺 | |
CN103083356B (zh) | 抗敏消炎水 | |
CN109077973B (zh) | 一种两剂碳酸发泡面膜及其制备方法与使用方法 | |
CN110507554A (zh) | 一种含有山茶籽油的天然无添加保湿霜及其制备方法 | |
CN105816369A (zh) | 一种制造肌龄多效蚕丝面膜的设备 | |
CN109394607A (zh) | 一种紫草健康舒敏乳液及其制备方法 | |
CN106821901A (zh) | 一种具有减少眼部周围皮肤皱纹作用的霜剂 | |
CN108066181A (zh) | 美白抗衰老护肤剂 | |
CN108670893B (zh) | 氨基酸洁面乳组合物及其制备方法 | |
CN108096121A (zh) | 一种防感染睫毛膏及其制备方法 | |
CN107841375A (zh) | 山银花精油及其制备方法 | |
CN108514544A (zh) | 脸部补水液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 448000 Building B 1702, Huitian Building, No. 4 Shenzhen Avenue, High-tech District, Jingmen City, Hubei Province Applicant after: Phoenix biological technology (Hubei) Co., Ltd. Address before: 448000 Building B 1702, Huitian Building, No. 4 Shenzhen Avenue, Gongdao District, Jingzhou City, Hubei Province Applicant before: Phoenix biological technology (Hubei) Co., Ltd. |
|
CB02 | Change of applicant information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180907 |
|
RJ01 | Rejection of invention patent application after publication |